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Association of knee pain and different
definitions of knee osteoarthritis with
health-related quality of life: a population-
based cohort study in southern Sweden
Aliasghar A. Kiadaliri1,2,10*, Carl Johan Lamm3, Maria Gerhardsson de Verdier4, Gunnar Engström5,
Aleksandra Turkiewicz1, L. Stefan Lohmander1,6,7 and Martin Englund1,8,9
Abstract
Background: While the impact of knee pain and knee osteoarthritis (OA) on health-related quality of life (HRQoL)
has been investigated in the literature, there is a lack of knowledge on the impact of different definitions of OA on
HRQoL. The main aim of this study was to measure and compare the impact of knee OA and its different
definitions on HRQoL in the general population.
Methods: A random sample of 1300 participants from Malmö, Sweden with pain in one or both knees in the past
12 months with duration ≥4 weeks and 650 participants without were invited to clinical and radiographic knee
examination. A total of 1527 individuals with a mean (SD) age 69.4 (7.2) participated and responded to both generic
(EQ-5D-3L) and disease-specific (the Knee injury and Osteoarthritis Outcome Score) questionnaires. Knee pain was
defined as pain during the last month during most of the days. Knee OA was defined radiographically (equivalent to
Kellgren and Lawrence grade ≥2) and clinically according to the American College of Rheumatology (ACR) criteria.
Results: Of participants with either knee pain or knee OA or both, 7 % reported no problem for the EQ-5D-3L
attributes. The corresponding proportion among references (neither knee pain nor OA) was 42 %. The participants with
knee pain and OA had all HRQoL measures lower compared to those with knee pain but no OA. The ACR clinical
definition of knee OA was associated with lower HRQoL than the definition based on radiographic knee OA (adjusted
difference −0.08 in UK EQ-5D-3L index score).
Conclusions: Applying different definitions of knee OA result in different levels of HRQoL and this is mainly explained
by the knee pain experience. These differences may lead to discrepant conclusions from cost-utility analyses.
Keywords: EQ-5D-3L, Knee osteoarthritis, Knee pain, KOOS, Quality of life, Sweden
Background
The prevalence of knee osteoarthritis (OA) rapidly in-
creases with age [1, 2]. Thus, it is expected that the num-
ber of people with knee OA will increase in the future due
to the steadily aging population and increasing prevalence
of obesity [3, 4]. The Global Burden of Disease (GBD)
2010 study ranked hip and knee OA as the 11th leading
cause of years lived with disability (YLD) and the 38th
highest contributor to disability-adjusted life years
(DALYs) among 291 conditions [5]. The share of total
DALYs attributed to hip and knee OA increased from
0.49 % in 1990 to 0.69 % in 2010 (an estimated 64 %
increase) [5].
OA is associated with substantial deteriorations in
health-related quality of life (HRQoL) [6]. A recent study
in the UK ranked OA as the 3rd greatest contributor to
loss of HRQoL among eleven long-standing health
conditions [7]. HRQoL constitutes a subjective and
multidimensional concept that includes the physical,
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psychological, and social functioning related to a health
condition or therapy [8]. HRQoL can be used as a criter-
ion to predict future health care consumption among
people with OA [9]. Therefore, measuring HRQoL is im-
portant not only to quantify the effects of disease and its
treatments, but also to aid informed decision-making in
allocation of often limited healthcare resources.
The relatively weak association between clinical symp-
toms of OA and radiographic evidence of the disease
has contributed to the existence of several definitions of
OA for study purposes. The multiple definitions repre-
sent a major challenge in studies on OA [10]. A radio-
graphic definition of OA (most commonly using
Kellgrene-Lawrence scale [11] with the cut-off of grade
2 or worse) and the clinical definition proposed by the
American College of Rheumatology (ACR) [12] are two
most commonly used definitions in the literature. While
the impact of knee pain and knee OA on HRQoL has
been investigated in the literature [13–15], there is a lack
of knowledge on the impact of different definitions of
OA on HRQoL. If such differences exist, the different
OA definitions used in health economic evaluations may
potentially yield different results and conclusions. Thus,
in the present study our main aim was to evaluate and
compare the impact of these two definitions of knee OA
on HRQoL. These were based on patient-reported knee
pain, and/or radiographically evident knee OA, as well
as clinically defined knee OA. We related our findings to
knee-healthy reference participants drawn from the
same source population.
Method
Setting and participants
The Malmö OA study (MOA) originated from the Malmö
Diet and Cancer Study (MDCS) cohort established between
1991 and 1996 [16]. All men aged 45–73 years and women
aged 44–74 years at the time of enrolment living in the city
of Malmö were invited to participate in the MDCS (n = 74
138). A cohort of 28 098 had completed baseline examina-
tions [17]. In the year 2007 a postal questionnaire about
knee pain was sent to a 10 000 random sample from the
MDCS who completed the MDCS baseline examination
and were still alive and resident in the Malmö area. Respon-
dents answered a question about whether they had knee
pain during the previous 12 months and its duration
(<1 week, 1–4 weeks, 1–3 months, >3 months). In the
second stage, a random sample of 1300 participants with
pain in one or both knees in the past 12 months and dur-
ation of at least 4 weeks (group A) and 650 participants
without knee pain or with knee pain for shorter duration
(group B) were invited to a clinical visit and radiographic
examination [16, 18]. Of these, 1028 (79 %) people from
group A and 499 (77 %) people from group B participated
and were included in the present study.
Radiographic evaluation and knee OA definitions
Both knees were radiographed in a weight-bearing and
semi-flexed position (knees in 10–15° of flexion) using a
posterior-anterior beam direction (film focus distance
110 cm, 60 kV and 10 mA) with the aid of fluoroscopy to
optimally align the tibia plateau. An independent senior
radiologist specialized in musculoskeletal conditions who
was blinded to the clinical data assessed joint space narrow-
ing and osteophytes according to the atlas from the Osteo-
arthritis Research Society International [16, 19]. We
classified a knee as having radiographic knee OA if one or
more of the following criteria were fulfilled in either the
medial, lateral tibiofemoral compartment or patellofemoral
compartment: joint space narrowing grade 2 or worse, the
sum of marginal osteophyte grades in the same compart-
ment 2 or worse, joint space narrowing grade 1 and osteo-
phyte grade 1 in the same compartment (approximating
Kellgren and Lawrence (KL) grade 2 or worse) [20].
All participants answered the 5 questions included in
the ACR clinical criteria for knee OA. We classified a
participant as having clinical OA if fulfilling ACR clinical
criteria according to the recursive partitioning method
[12]. Five items are included in the ACR criteria (28): (a)
knee pain for most days of the prior month, (b) crepitus
on active joint motion, (c) morning stiffness of duration
< 30 min, (d) age ≥ 38 years, and (e) bony enlargement of
the knee on examination. Knee OA was present if items
“a”, “b”, “c”, “d” or items “a”, “b”, “e” or items “a” and “e”
were present [12]. We used the ACR clinical criteria “a”
(i.e. knee pain for most days of the prior month) to de-
fine knee pain in our study. It should be noted that as
this definition was different from the definition of knee
pain in the first stage and also due to gap between the
first and second stages of the study, people who defined
as having knee pain in the first stage could have been
classified as not having knee pain and vice versa.
We classified participants into four exposure groups
based on their clinical and radiographic knee status: 1)
reference group having neither knee pain nor radiographic
or clinically-defined knee OA (n = 744), 2) knee pain with-
out OA, i.e., participants with knee pain but without radio-
graphic or clinically-defined knee OA (n = 169), 3) knee
pain with OA, i.e., participants with knee pain having either
radiographic knee OA or clinically-defined knee OA (n =
402), and 4) radiographic knee OA but no knee pain, i.e.
participants without knee pain but fulfilling the radio-
graphic defined knee OA (n = 186). A total of 26 partici-
pants with missing value on knee OA status were excluded.
Additionally, to assess the impact of different definition of
knee OA on HRQoL, the participants with knee OA (i.e.,
groups 3 & 4) were collapsed, then classified into three
subgroups: those fulfilling the criteria for a) radiographic
knee OA (n = 282), b) clinical knee OA (n = 157), and c)
both clinical and radiographic knee OA (n = 149).
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Health-related quality of life measurement
The EQ-5D-3L is a generic multi-attribute instrument to
elicit health-related preferences. The EQ-5D-3L covers
five attributes: mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression. Each attribute has
three levels: no problems, moderate problems, and se-
vere problems, resulting in 243 (35) possible health states
[21]. The responses to these attributes are weighted
based on the preferences elicited from a general popula-
tion/patients sample to calculate an index score. We
used the UK [22] and recently developed Swedish [23]
sets of preferences to calculate the index score. The UK
EQ-5D-3L scores range between −0.594 and 1 (full
health), while the Swedish scores range between 0.340
and 0.969.
The Knee injury and Osteoarthritis Outcome Score
(KOOS) is a validated knee specific instrument [24, 25].
The KOOS is a 42-item self-administered question-
naire covering 5 subscales: pain, other symptoms,
function in daily living (ADL), function in sport and
recreation (Sport/Rec) and knee related quality of life
(QoL). All items have five possible answer options
scored from 0 (no problems) to 4 (extreme problems).
A normalized score (100 indicating no symptoms and
0 indicating extreme symptoms) is calculated for each
subscale. As our participants were an elderly popula-
tion, we included a sixth answer option (not applic-
able) into the case report form for the subscale Sport/
Rec. If the box “not applicable” was marked, the item
was treated as missing data. Since a large number of
participants selected this option, we decided not to in-
clude this subscale in our analysis.
Explanatory variables (confounders)
To avoid potential confounder bias, the following ex-
planatory variables were included in our regression ana-
lysis: sex, age, body mass index (BMI), comorbidity,
years of education, employment, and smoking. Age and
BMI were included as continuous variables. Comorbidity
was defined as presence of self-reported doctor’s diagno-
sis of one or more of the following comorbidities: back
problems, other joint problems (except knees), asthma/
lung disease, hypertension, heart disease, stroke, leg ar-
tery disease, neurological disease, diabetes, cancer, gas-
tric ulcer, renal disease, anemia/blood disease, eye
disease/visual impairment, balance disorder, depression,
and other psychiatric disorder. Three groups were de-
fined: no comorbidity, single comorbidity, and multiple
comorbidities. Years of education were categorized in
three groups: ≤9 years, 9–12 years, and >12 years. Em-
ployment was defined in three categories: employed, un-
employed, and retired. We grouped smoking in three
groups as: never, current smoker, and ex-smoker.
Statistical analysis
We applied weighting to account for a possible selection
bias that might arise from non-responses in the first or
second part in the MOA study [26]. A logistic regression
model with sex, age on 1 January 2007, education, smok-
ing, and BMI as covariates was used to estimate the
probability of response in the first stage of survey. Simi-
lar logistic regression models including knee pain during
last 12 months as an additional covariate were applied to
estimate the probability of participation and attendance
at the clinical examination. The sampling weights (the
reciprocal of the sampling probability for those with and
without knee pain ≥ 4 weeks duration) were multiplied
by the weights for response, participation and attend-
ance to construct the final weights used in analyses.
We present continuous variables using means and
standard deviations. The mean differences between
groups were tested using one-way analysis of variance
(ANOVA) and Bonferroni post-hoc tests. Proportions
were compared using Pearson Chi-2 test. Adjusted ana-
lysis was conducted using Ordinary least squares regres-
sion with robust standard errors. Due to the skewed
distribution of the EQ-5D-3L data, several different
methods have been applied to these data in the literature
[27, 28], but ordinary least squares (OLS) regression is
considered as a simple and valid approach [29]. The lin-
earity of the continuous variables was checked using de-
sign variables and residual plots and non-linearity was
modelled using fractional polynomial. The possible rea-
sonable linear and non-linear interactions were also
checked using the same approach [30]. Potential con-
founders (age, sex, body mass index, comorbidity, years
of education, employment, and smoking) were included
in the models regardless of their significance level.
STATA version 13 (StataCorp LP, College Station, TX,
USA) was used for statistical analysis.
Results
The mean (SD) age and BMI of the participants included
was 69.4 (7.2) and 27.7 (4.9), respectively, and 63.8 %
were women (Table 1). Except sex and smoking, there
were no statistically significant differences in other ex-
planatory variables across the study groups.
The mean UK EQ-5D-3L index scores were 0.69 (95 %
CI 0.67 to 0.70) and 0.85 (95 % CI 0.83 to 0.86) in non-
reference and reference groups, respectively. Across
non-reference groups, the participants with radiographic
knee OA without knee pain had generally less problems
on the EQ-5D-3L dimensions and reported statistically
significantly higher HRQoL scores compared with the
participants who had knee pain (Table 2). Among the
participants with knee pain, the participants with both
knee pain and knee OA reported lower HRQoL scores.
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Among the participants with knee OA, those with
radiographic knee OA generally experienced less prob-
lems in the EQ-5D-3L dimensions and reported statisti-
cally significantly higher HRQoL scores than the
participants fulfilled clinical knee OA definition (Table 3).
The participants with both radiographic and clinical
knee OA reported lower scores on three KOOS sub-
scales compared with the participants with clinically de-
fined knee OA.
Controlling for potential confounders in the regression
analysis did not alter our unadjusted findings in the full
sample (Table 4). Generally the outcome measures were
ranked in following order: reference group > radio-
graphic knee OA without knee pain > knee pain without
knee OA > knee pain with knee OA. Among the partici-
pants with knee OA, while the participants with radio-
graphic knee OA reported higher scores on all outcome
measures, the difference between two other groups (i.e.,
clinical knee OA only and clinical and radiographic knee
OA) was statistically significant only on the KOOS-Pain
subscale.
Discussion
We measured and compared the impact of knee pain
and knee OA on HRQoL, using both generic and
disease-specific scales, in a large population-based co-
hort from southern Sweden. First, our results confirmed
the expected notion that participants with either knee
pain or knee OA (either clinically or radiographically
defined) reported lower HRQoL scores than reference
Table 1 Characteristics of participants included in the Malmö
osteoarthritis study (MOA)
Reference
group
(n = 744)
Knee pain
without knee
OA (n = 169)
Knee pain
with knee
OA (n = 402)
Radiographic
knee OA without
pain (n= 186)
Women, % 63.0 70.4 63.7 61.3
Age, years (SD) 68.7 (7.2) 68.4 (7.3) 70.1 (7.2) 71.5 (6.7)
BMI (SD) 26.7 (4.3) 27.8 (4.8) 28.9 (5.5) 28.8 (5.1)
Comorbidity, %
Single 32.5 26.6 23.1 28.0
Multiple 46.1 59.2 64.9 53.2
Years of education, %
≤ 9 years 35.0 30.3 43.3 34.4
> 9 years &
≤ 12 years
38.3 43.2 34.7 44.8
>12 years 26.7 26.5 22.0 20.8
Smoking, %
Current
smoker
14.1 12.7 12.3 11.8
Ex-smoker 45.1 46.4 46.0 42.5
Employment, %
Employed 25.3 23.7 14.7 15.6
Retired 72.2 72.8 80.9 81.7
Table 2 Percentage (95 % CI) of participants with moderate/severe problems in the EQ-5D-3L attributes, mean (95 % CI) EQ-5D-3L
index and KOOS scores in the full sample
Reference group
(n = 744)
Knee pain without knee
OA (n = 169)
Knee pain with knee
OA (n = 402)
Radiographic knee OA without
knee pain (n = 186)
EQ-5D-3L dimension
Mobility 11.5 (8.9 to 14.8) 32.6 (23.1 to 43.8)a 52.2 (44.8 to 59.5)ab 34.7 (25.4 to 45.5)ac
Self-care 0.2 (0.1 to 0.5) 2.7 (1.3 to 5.6)a 7.3 (3.5 to 14.5)a 3.6 (1.0 to 12.3)a
Usual activities 5.6 (3.9 to 8.0) 21.9 (14.3 to 32.0)a 24.8 (20.1 to 30.3)a 10.0 (5.1 to 18.7)bc
Pain/discomfort 35.9 (31.8 to 40.3) 88.1 (76.1 to 94.5)a 96.7 (92.1 to 98.7)ab 70.4 (60.1 to 78.9)abc
Anxiety/depression 17.5 (14.3 to 21.1) 30.2 (20.9 to 41.3)a 32.2 (25.9 to 39.4)a 21.4 (13.9 to 31.4)
No problem at any dimension (full health) 54.2 (50.0 to 58.6) 7.7 (2.9 to 19.0)a 3.1 (1.2 to 7.8)a 22.6 (15.2 to 32.2)abc
Mean UK EQ-5D-3L index score 0.89 (0.87 to 0.90) 0.71 (0.67 to 0.75)a 0.67 (0.64 to 0.69)ab 0.77 (0.72 to 0.82)abc
Mean Swedish EQ-5D-3L index score 0.93 (0.93 to 0.94) 0.87 (0.85 to 0.89)a 0.84 (0.83 to 0.85)ab 0.89 (0.87 to 0.91)abc
KOOS subscale
Pain 92.8 (91.8 to 93.8) 68.9 (64.3 to 73.4)a 55.4 (52.9 to 57.8)ab 81.4 (78.2 to 84.6)abc
Symptoms 66.1 (65.4 to 66.8) 56.7 (54.4 to 58.9)a 48.2 (46.5 to 50.0)ab 61.6 (59.5 to 63.8)abc
ADL 91.3 (90.1 to 92.6) 70.3 (65.6 to 74.9)a 56.2 (53.1 to 59.3)ab 80.1 (76.4 to 83.9)abc
QoL 86.4 (84.9 to 87.9) 56.9 (51.6 to 62.1)a 40.1 (37.4 to 42.9)ab 66.4 (61.9 to 70.8)abc
ADL function in daily living, QoL knee-related quality of life
aP < 0.05 compared with reference group
bP < 0.05 compared with knee pain without knee OA
cP < 0.05 compared with knee pain with knee OA
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participants free of such knee pain and with no knee
OA. We also found that knee pain without knee OA had
more profound negative impact on HRQoL than radio-
graphic knee OA without knee pain. Moreover, among
participants with knee OA (either radiographically or
clinically defined), those with clinical knee OA accord-
ing to the ACR clinical definition reported lower scores
of HRQoL than those who had radiographic knee OA
not fulfilling the ACR clinical criteria.
The effect of different OA definitions in the study of
prevalence and incidence of OA is well documented,
where it was reported that radiographic definition of OA
resulted in the highest prevalence estimates [10]. The
effect of different OA definitions on HRQoL is however
much less well investigated, which may have important
implications for the interpretation of findings from
health economic evaluations. Our results suggest that
the knee OA definition based on the ACR clinical cri-
teria was associated with lower HRQoL than the defin-
ition based on radiographic knee OA. The presence of
knee pain in the ACR clinical definition is a possible ex-
planation for this finding. Interestingly, in our full sam-
ple, people with knee pain had lower HRQoL compared
with people with radiographic features of knee OA with-
out knee pain. In our sample, only 96 (22 %) of partici-
pants in the radiographic knee OA group experienced
Table 3 Percentage (95 % CI) of participants with moderate/severe problems in the EQ-5D-3L attributes, mean (95 % CI) EQ-5D-3L
index and KOOS scores among participant with knee osteoarthritis (OA)
Radiographic knee
OA (n = 282)
Clinical knee
OA (n = 157)
Clinical and radiographic
knee OA (n = 149)
EQ-5D-3L dimension
Mobility 40.5 (32.1 to 49.5) 38.9 (29.3 to 49.5) 59.7 (48.7 to 69.8)ab
Self-care 5.5 (2.1 to 13.6) 5.0 (2.7 to 9.4) 5.3 (2.6 to 10.5)
Usual activities 12.2 (7.6 to 18.9) 27.4 (20.2 to 36.0)a 26.5 (19.3 to 35.2)a
Pain/discomfort 76.3 (67.8 to 83.2) 98.6 (95.6 to 99.5)a 94.4 (82.2 to 98.4)a
Anxiety/depression 23.4 (16.7 to 31.8) 36.0 (25.5 to 48.1) 29.7 (22.0 to 38.7)
No problem at any dimension (full health) 18.3 (12.4 to 26.1) 0.9 (0.2 to 3.5)a 5.6 (1.6 to 17.8)ab
Mean UK EQ-5D-3L index score 0.75 (0.71 to 0.79) 0.67 (0.63 to 0.71)a 0.66 (0.61 to 0.70)a
Mean Swedish EQ-5D-3L index score 0.88 (0.87 to 0.90) 0.84 (0.82 to 0.86)a 0.84 (0.81 to 0.86)a
KOOS subscale
Pain 75.6 (72.4 to 78.9) 58.6 (54.8 to 62.4)a 52.0 (47.5 to 56.6)ab
Symptoms 59.5 (57.6 to 61.4) 48.2 (45.6 to 50.7)a 45.0 (42.4 to 47.6)a
ADL 74.6 (70.8 to 78.4) 59.5 (54.4 to 64.6)a 53.6 (49.2 to 58.1)ab
QoL 60.5 (56.5 to 64.5) 44.2 (40.1 to 48.3)a 35.9 (30.3 to 41.5)ab
ADL function in daily living, QoL knee-related quality of life
aP < 0.05 compared with radiographic knee OA
bP < 0.05 compared with clinical knee OA
Table 4 The effects of knee osteoarthritis (OA) on health-related quality of life: results from regression analysis
UK EQ-5D-3L
index score
Swedish EQ-5D-3L
index score
Pain
(KOOS)
Symptoms
(KOOS)
ADL
(KOOS)
QoL
(KOOS)
Full samplea
Reference group 0.00 (ref)
Knee pain without knee OA −0.15*** −0.06*** −22.69*** −8.78*** −19.67*** −27.41***
Knee pain with knee OA −0.19*** −0.08*** −35.14*** −16.92*** −31.94*** −43.48***
Radiographic knee OA without pain −0.09*** −0.03** −10.04*** −4.27*** −8.72*** −18.47***
Participants with knee OAa
Radiographic knee OA 0.00 (ref)
Clinical knee OA −0.08*** −0.04*** −17.92*** −10.91*** −17.40*** −18.40***
Clinical and radiographic knee OA −0.10** −0.05*** −23.79*** −14.08*** −22.50*** −24.42***
ADL function in daily living, QoL Knee-related quality of life
***,** p < 0.001, and p < 0.01 significance level compared to the reference group
aBoth models were additionally adjusted for age, sex, body mass index, comorbidity, years of education, employment, and smoking
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pain in most days during last month and interestingly
the EQ-5D-3L index score for these 96 participants
(0.66) was equal to participants in the clinical knee OA
group (0.66).
Our finding of differences in HRQoL measures be-
tween persons fulfilling different definitions of knee
OA (i.e., radiographic or clinical ACR criteria) has an
important implication for cost-utility analyses. The
difference in the mean HRQoL according to knee OA
definition will result in different estimates of quality-
adjusted life years (QALYs) which might yield discrep-
ant and potentially conflicting conclusions from these
analyses. For example, in our study, if a hypothetical
intervention improved HRQoL of participants with
knee OA to the level of the reference group (0.85),
then QALYs gained from using clinical knee OA to
define participants with knee OA (0.85 minus 0.66)
would be 1.9 times higher than applying radiographic
signs for definition of knee OA (0.85 minus 0.75).
This translates into less favorable cost-effectiveness
ratios using radiographic signs to define knee OA.
This should be taken into account by policy makers
when using cost-utility analysis to make decisions on
funding of knee OA interventions.
In line with previous studies [31–33], we found that
pain was the most affected dimension in the EQ-5D-
3L questionnaires among participants with knee pain
and knee OA. In our study the participants suffering
from both knee pain and knee OA reported lower
scores for all KOOS subscales compared to people
with either knee pain or radiographic knee OA only.
In addition, among participants with knee OA, radio-
graphic knee OA without pain was associated with
higher HRQoL than radiographic knee OA with pain.
These findings suggest that the combination of knee
pain and knee OA results in additional negative im-
pact on HRQoL compared with knee pain or radio-
graphic knee OA alone.
Mean EQ-5D-3L index score among participants
with knee pain and knee OA in our study (0.65) was
higher than people with knee OA in Singapore (0.49)
[31] and UK (0.44) [34] using the UK weights. Differ-
ences in severity of knee OA, with a substantial por-
tion of participants in those studies having severe
disease and waiting for TKR might be an explanation.
However, our EQ-5D-3L score is comparable to
values reported among Swedish people waiting for
total hip replacement (0.73) [35] and ACL surgery
(0.69) [36]. This similarity between Swedish patients
with different severity highlights another potential ex-
planation for higher scores among the Swedish pa-
tients than patients in other countries, i.e., clinical,
environmental, organizational, and cultural differences
between patients and countries in these studies.
The results of this study should be interpreted in light
of some limitations. The MOA study originated from
the MDCS whose participants were shown to have a
slightly lower mortality than non-participants [17].
Eleven percent of people with knee pain in the past
12 months and 30 % of participants without knee pain
in past 12 month did not agree to participate in our
study. If non-participation was associated with both knee
pain/knee OA and HRQoL through unmeasured factors
in our weighting exercise, then this is a potential source
of selection bias and also could limit the generalizability
of our findings. Another limitation of the current study
is the self-reported nature of some explanatory variables
(e.g., self-reported doctor-diagnosed comorbidity and
smoking) that might be prone to recall bias or underre-
porting. The cross-sectional design of our study implies
that any causal inference should be avoided.
Conclusion
The current study showed that participants with knee
pain (with and without knee OA) have poorer HRQoL,
measured by both generic and disease-specific scales,
than the references. The presence of knee OA has add-
itional negative impact on HRQoL above the knee pain
alone. Importantly, we found that applying different defi-
nitions of knee OA resulted in different levels of HRQoL
and this was mainly explained by the knee pain experi-
ence. These differences are important to take into ac-
count when assessing the impact of knee OA on HRQoL
and interpreting the results of cost-utility analyses.
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